Related Drugs: Eliquis
Apixaban (Brand name: Eliquis) is prescribed for the prevention of strokes or blood clots in people who have atrial fibrillation. It also treats and prevents blood clots in the legs and/or lungs. Apixaban works by stopping the action of a natural substance in the body that helps form blood clots.
In general, the names and strengths of drugs can vary globally due to differing marketing strategies. Any variations need to be approved by your prescriber. In apixaban’s case, the name differs across markets. PharmacyChecker is not aware of strength differences across countries.
Apixaban is marketed under the brand name Eliquis in much of the world by Pfizer and Bristol-Myers Squibb.
There are many generic alternatives of Eliquis approved in Canada now. They carry the same active ingredient as Eliquis, apixaban. In Canada, apixaban is approved by Health Canada to be manufactured and marketed by the following companies:
Teva Canada Limited marketed under the name Teva-Apixaban
Pro Doc Limitee marketed under the name Pro-Apixaban
Laboratoire Riva Inc marketed under the name Riva Apixaban
Sandoz Canada Incorporated marketed under the name Sandoz Apixaban SDZ
Sun Pharma Canada Inc marketed under the name Taro-Apixaban
Marcan Pharmaceuticals Inc marketed under the name Mar-Apixaban
Mint Pharmaceuticals Inc marketed under the name Mint-Apixaban
Natco Pharma (Canada) Inc marketed under the name Nat-Apixaban
Nora Pharma Inc marketed under the name NRA-Apixaban
Auro Pharma Inc marketed under the name Auro-Apixaban
Biomed pharma marketed under the name Bio-apixaban
Bristol Myers Squibb marketed under the name Eliquis
JAMP Pharma Corporation marketed under the name JAMP apixaban
Mantra Pharma Inc marketed under the name M-apixaban
Accord Healthcare Inc marketed under the name ACH-apixaban
Angita Pharma Inc. marketed under the name AG-apixaban
Sivem Pharmaceuticals ULC marketed under the name Apixaban
Sanis Health Inc approved under the name Apixaban
Apotex Inc marketed under the name APO-apixaban
Apixaban is manufactured and marketed under the name Apigat in India by Natco Pharma. In 2019, the Delhi High Court dismissed attempts by Bristol-Myers Squibb to protect its patented apixaban against Natco’s Apigat.
The U.S. FDA has approved the following companies to market a generic version: Indoco, Hetero Labs, Sun Pharma, and Accord, but approval does not equal availability. A generic alternative for Eliquis will most likely be launched in the United States in April 2028. Brand Eliquis is among the first ten medications proposed for Medicare price negotiations in the United States; negotiated pricing would go into effect in 2026.
Apixaban (Brand name: Eliquis) is prescribed for the prevention of strokes or blood clots in people who have atrial fibrillation. It also treats and prevents blood clots in the legs and/or lungs.
Apixaban works by stopping the action of a natural substance in the body that helps form blood clots.
In general, the names and strengths of drugs can vary globally due to differing marketing strategies. Any variations need to be approved by your prescriber. In apixaban’s case, the name differs across markets. PharmacyChecker is not aware of strength differences across countries.
Apixaban is marketed under the brand name Eliquis in much of the world by Pfizer and Bristol-Myers Squibb.
There are many generic alternatives of Eliquis approved in Canada now. They carry the same active ingredient as Eliquis, apixaban. In Canada, apixaban is approved by Health Canada to be manufactured and marketed by the following companies:
Teva Canada Limited marketed under the name Teva-Apixaban
Pro Doc Limitee marketed under the name Pro-Apixaban
Laboratoire Riva Inc marketed under the name Riva Apixaban
Sandoz Canada Incorporated marketed under the name Sandoz Apixaban SDZ
Sun Pharma Canada Inc marketed under the name Taro-Apixaban
Marcan Pharmaceuticals Inc marketed under the name Mar-Apixaban
Mint Pharmaceuticals Inc marketed under the name Mint-Apixaban
Natco Pharma (Canada) Inc marketed under the name Nat-Apixaban
Nora Pharma Inc marketed under the name NRA-Apixaban
Auro Pharma Inc marketed under the name Auro-Apixaban
Biomed pharma marketed under the name Bio-apixaban
Bristol Myers Squibb marketed under the name Eliquis
JAMP Pharma Corporation marketed under the name JAMP apixaban
Mantra Pharma Inc marketed under the name M-apixaban
Accord Healthcare Inc marketed under the name ACH-apixaban
Angita Pharma Inc. marketed under the name AG-apixaban
Sivem Pharmaceuticals ULC marketed under the name Apixaban
Sanis Health Inc approved under the name Apixaban
Apotex Inc marketed under the name APO-apixaban
Apixaban is manufactured and marketed under the name Apigat in India by Natco Pharma. In 2019, the Delhi High Court dismissed attempts by Bristol-Myers Squibb to protect its patented apixaban against Natco’s Apigat.
The U.S. FDA has approved the following companies to market a generic version: Indoco, Hetero Labs, Sun Pharma, and Accord, but approval does not equal availability. A generic alternative for Eliquis will most likely be launched in the United States in April 2028. Brand Eliquis is among the first ten medications proposed for Medicare price negotiations in the United States; negotiated pricing would go into effect in 2026.
The total price includes shipping fees which typically cover an entire order, making it more economical to purchase multiple medications in the same order.
U.S. government officials have stated that individuals who order non-controlled prescription drugs from Canada or other foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted - although it is technically not legal for individuals to import most prescription drugs. The U.S FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in other countries. Read how regulations may differ by country.
The 
icon means that this online pharmacy only ships from dispensing pharmacies located in Canada. Separately, the Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.
For more about Tier 1 international pharmacies click here.
The Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.
For more about Tier 1 international pharmacies click here.
The 
icon means that this online pharmacy accredited by PharmacyChecker fills prescription orders through either their own pharmacy or dispensing pharmacy partners located in Australia, India, Mauritius, New Zealand, Turkey, the UK, or Canada. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.
For information about Tier 1 international pharmacies click here.
PharmacyChecker provides free monthly email updates of the latest prices.
